Ian Grimes

408 total citations
20 papers, 238 citations indexed

About

Ian Grimes is a scholar working on Immunology, Infectious Diseases and Surgery. According to data from OpenAlex, Ian Grimes has authored 20 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Ian Grimes's work include Inflammatory Bowel Disease (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Ian Grimes is often cited by papers focused on Inflammatory Bowel Disease (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Ian Grimes collaborates with scholars based in United States and Switzerland. Ian Grimes's co-authors include Sumona Saha, Freddy Caldera, Mary S. Hayney, Arnold Wald, Mark Reichelderfer, Patrick Pfau, Luke Hillman, Bret J. Spier, Keith L. Knutson and Kelly Chun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Ian Grimes

18 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Grimes United States 9 90 66 55 48 46 20 238
A. Meerveld-Eggink Netherlands 11 68 0.8× 13 0.2× 71 1.3× 106 2.2× 57 1.2× 20 283
Tumas Beinortas United Kingdom 6 192 2.1× 9 0.1× 97 1.8× 54 1.1× 50 1.1× 9 319
Samantha Zullow United States 5 23 0.3× 80 1.2× 30 0.5× 88 1.8× 29 0.6× 19 224
Diego Torres‐Carranza Spain 8 75 0.8× 7 0.1× 28 0.5× 29 0.6× 42 0.9× 10 297
Erol Demir Türkiye 12 131 1.5× 12 0.2× 42 0.8× 44 0.9× 63 1.4× 59 344
Ioan Sas Romania 9 73 0.8× 5 0.1× 75 1.4× 41 0.9× 40 0.9× 42 298
Agathe Pardon France 9 96 1.1× 25 0.4× 11 0.2× 49 1.0× 35 0.8× 15 313
Ayman Al Jurdi United States 9 141 1.6× 6 0.1× 38 0.7× 25 0.5× 42 0.9× 29 242
G. Thomas Canada 9 46 0.5× 7 0.1× 73 1.3× 65 1.4× 10 0.2× 18 296
Tom Pembroke United Kingdom 10 19 0.2× 19 0.3× 129 2.3× 137 2.9× 177 3.8× 24 408

Countries citing papers authored by Ian Grimes

Since Specialization
Citations

This map shows the geographic impact of Ian Grimes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Grimes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Grimes more than expected).

Fields of papers citing papers by Ian Grimes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Grimes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Grimes. The network helps show where Ian Grimes may publish in the future.

Co-authorship network of co-authors of Ian Grimes

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Grimes. A scholar is included among the top collaborators of Ian Grimes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Grimes. Ian Grimes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caldera, Freddy, Francis A. Farraye, Brian M. Necela, et al.. (2022). Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflammatory Bowel Diseases. 29(8). 1202–1209. 11 indexed citations
2.
Knutson, Keith L., Sumona Saha, Arnold Wald, et al.. (2022). Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 28(11). 1781–1786. 16 indexed citations
3.
4.
Caldera, Freddy, Keith L. Knutson, Sumona Saha, et al.. (2021). Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls. The American Journal of Gastroenterology. 117(1). 176–179. 26 indexed citations
5.
Hayney, Mary S., et al.. (2020). Sa1768 A MAJORITY OF YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE SUSTAINED IMMUNITY TO HEPATITIS B. Gastroenterology. 158(6). S–415. 1 indexed citations
6.
Caldera, Freddy, Luke Hillman, Sumona Saha, et al.. (2019). Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial. Inflammatory Bowel Diseases. 26(4). 593–602. 66 indexed citations
7.
Caldera, Freddy, Sumona Saha, Arnold Wald, et al.. (2018). 279 - Randomized Trial Evaluating the Immunogenicity of High Dose vs. Standard Dose Influenza Vaccine in IBD Patients on Anti-TNF Monotherapy. Gastroenterology. 154(6). S–69. 1 indexed citations
8.
Megna, Bryant, Jennifer M. Weiss, Sumona Saha, et al.. (2018). Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease. Gastrointestinal Endoscopy. 89(2). 373–379.e2. 20 indexed citations
9.
Caldera, Freddy, Sumona Saha, Arnold Wald, et al.. (2018). Mo1882 - Vedolizumab Does not affect Influenza Vaccine Antibody Response. Gastroenterology. 154(6). S–837. 1 indexed citations
10.
Grimes, Ian, et al.. (2016). Low Yield and High Cost of Gastric and Duodenal Biopsies for Investigation of Symptoms of Abdominal Pain During Routine Esophagogastroduodenoscopy. Digestive Diseases and Sciences. 62(2). 418–423. 10 indexed citations
11.
Patel, Ravi & Ian Grimes. (2016). Vedolizumab in Inflammatory Bowel Disease: A Retrospective Review of Clinical Efficacy, Extraintestinal Manifestations and Adverse Reactions. The American Journal of Gastroenterology. 111. S317–S318. 2 indexed citations
12.
Grimes, Ian, et al.. (2016). Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.. PubMed. 36(3). 845–52. 3 indexed citations
13.
Bacher, Jeffery W., Dawn M. Albrecht, Ian Grimes, et al.. (2015). Improved Detection of Microsatellite Instability in Early Colorectal Lesions. PLoS ONE. 10(8). e0132727–e0132727. 35 indexed citations
14.
Benson, Mark, Ian Grimes, Deepak V. Gopal, et al.. (2014). Influence of Previous Night Call and Sleep Deprivation on Screening Colonoscopy Quality. The American Journal of Gastroenterology. 109(8). 1133–1137. 11 indexed citations
15.
Grimes, Ian, et al.. (2013). Predictors of Recurrent Ingestion of Gastrointestinal Foreign Bodies. SHILAP Revista de lepidopterología. 27(1). e1–e4. 24 indexed citations
16.
Benson, Mark, Ian Grimes, Deepak V. Gopal, et al.. (2013). 356 Influence of Previous Night Call and Sleep Deprivation on Screening Colonoscopy Quality. Gastrointestinal Endoscopy. 77(5). AB145–AB146. 3 indexed citations
17.
Grimes, Ian, et al.. (2013). The Role of Azathioprine and 6-Mercaptopurine in the Development of Colorectal Cancer among Patients with Crohnʼs Disease and Ulcerative Colitis. The American Journal of Gastroenterology. 108. S536–S536. 1 indexed citations
18.
Grimes, Ian, Anurag Soni, & Freddy Caldera. (2012). Reactivation of Latent Tuberculosis After Treatment With Biologic Therapy. Inflammatory Bowel Diseases. 18. S14–S14. 1 indexed citations
19.
Grimes, Ian, Bret J. Spier, & Mark Reichelderfer. (2009). Mercury ingestion retrieved by colonoscopy. Gastrointestinal Endoscopy. 70(3). 559–560. 6 indexed citations
20.
Spier, Bret J., et al.. (2009). Predictors of Recurrent Ingestion of Gastrointestinal Foreign Bodies. Gastrointestinal Endoscopy. 69(5). AB317–AB317.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Meerveld-Eggink Breakdown of academic impact, for papers by Tumas Beinortas Breakdown of academic impact, for papers by Samantha Zullow Breakdown of academic impact, for papers by Diego Torres‐Carranza Breakdown of academic impact, for papers by Erol Demir Breakdown of academic impact, for papers by Ioan Sas Breakdown of academic impact, for papers by Agathe Pardon Breakdown of academic impact, for papers by Ayman Al Jurdi Breakdown of academic impact, for papers by G. Thomas Breakdown of academic impact, for papers by Tom Pembroke
Rankless by CCL
2026